Is the total review time of new medical devices related to the size of the company?: Medical devices development and its related factors in Japan

Authors

  • Naoki Tomotsugu Department of Clinical Medicine (Pharmaceutical Medicine), Kitasato University School of Pharmacy
  • Masayuki Kaneko Department of Clinical Medicine (Pharmaceutical Medicine), Kitasato University School of Pharmacy
  • Akane Takayama Department of Clinical Medicine (Pharmaceutical Medicine), Kitasato University School of Pharmacy
  • Mamoru Narukawa Department of Clinical Medicine (Pharmaceutical Medicine), Kitasato University School of Pharmacy

DOI:

https://doi.org/10.21423/JRS-V06N02P024

Keywords:

medical device, device development, PMDA, Japan

Abstract

Japan has one of the largest medical device markets in the world, but most devices used in Japan are pioneered by foreign medical device companies. On the other hand, medical device companies in Japan have significant potential to develop innovative medical devices. Through this research, we aim to elucidate the factors related to the total review time of new medical devices so that innovative medical devices would be developed sooner. Using the lists of approved medical devices disclosed by the Pharmaceuticals and Medical Devices Agency (PMDA), we chose all the new medical devices that were approved in Japan between Fiscal Year (FY) 2009 and 2015. We conducted two main types of analyses based on the total review time after submission and sales of the companies. The total review time tends to decrease with "Year of approval by the PMDA'' in FY 2009 to 2015 (p < 0.001). Moreover, the total review time of small and medium-sized companies is greater than that of large companies (p = 0.004). In conclusion, the total review time of new medical devices in Japan appears to be related to the following two factors: (1) year of approval, and (2) size of the enterprise.

https://doi.org/10.21423/jrs-v06n02p024 (DOI assigned 1/24/2019)

References

Basu, S. & Hassenplug, J. C. (2012). Patient access to medical devices - A comparison of U.S. and European Review Processes. New England Journal of Medicine, 367, 485-488.

Health Policy Bureau, Ministry of Health, Labour and Welfare. (2014). Annual Report on Statistics of Production by Pharmaceutical Industry in 2014. Retrieved May 2018 from http://www.mhlw.go.jp/topics/yakuji/2014/nenpo/dl/insathu_e.pdf

Ikeno, F., Ikeda, K. & Uchida, T. (2014). Patient access to medical devices - what about Japan, the second largest medical device market? Cardiovascular Intervention and Therapetics, 29, 1-3.

International Medical Device Regulators Forum. (2011). Retrieved May 2018 from http://www.imdrf.org/

International Medical Device Regulators Forum. (2012). Global Harmonization Task Force, Study Group 1 - Pre-market Evaluation. Principles of Medical Devices Classification (revised). Retrieved May, 2018 from http://www.imdrf.org/documents/doc-ghtf-sg1.asp

Kakudo, T. (2014). Medical device industry policy by the Ministry of Economy, Trade and Industry (in Japanese). Journal of the Japan Society for Intellectual Production, 10(2), 1-5

Kanda, Y. (2012). Investigation of the freely-available easy-to-use software EZR (Easy R) for medical statistics. Bone Marrow Transplantation, 48, 452-458.

Nakano, A., Kitakaze, M. & Taenaka, Y. (2014). Actual conditions and perspectives of medical device development and productization for academic researchers (in Japanese). Pharmaceutical and Medical Device Regulatory Science, 45(12), 988-991.

Nakano, S., Kodama, F. & Kano S. (2009). Definition of the device lag and its measurement (in Japanese). Japanese Journal of Medical Instrumentation, 79, 273-285.

Oshita, H.& Ikeno, F. (2016). Development of Medical Devices and Venture Capitals (in Japanese). Tokyo: Gentosha Media Consulting.

Pharmaceuticals and Medical Devices Agency (PMDA). (n.d.). List of Approved Products (New & Improved Medical Devices). Retrieved May, 2018 from https://www.pmda.go.jp/english/review-services/reviews/approved-information/devices/0001.html

Pharmaceuticals and Medical Devices Agency (PMDA). (2009). Mid-Term Plan of the Pharmaceuticals and Medical Devices Agency. Retrieved May, 2018 from https://www.pmda.go.jp/files/000152334.pdf

Shoji, K. (2015). Global development strategy based on medical device market in the world wide (in Japanese). Regulatory Science of Medical Products, 5(3), 203-209.

Uchida, T., Kobayashi, H. & Ishihara, T. (2015). A Current Global Strategy in a Medtech Startup (in Japanese). emph{Regulatory of Science of Medical Products, 5(3), 211-217.

Downloads

Published

2018-11-05

Issue

Vol 6, No 2 (2018)

Section

Scientific Articles

License

Copyright (c) 2018 Journal of Regulatory Science

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

By submitting content to the Journal of Regulatory Science (JRS), authors agree to the following terms:

  1. Authors retain copyright and grant the JRS the right of first publication. Authors retain patent, trademark, and other intellectual property rights (including research data) and grant third parties the right to use, reproduce, and share the article according to the Creative Commons — Attribution-NonCommercial 4.0 International — CC BY-NC 4.0 license agreement. The JRS is an open access journal and, as a result, articles are free to use with proper acknowledgment of the work's authorship and initial publication in this journal.

  2. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process.

  3. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article.

  4. The publication of the submission has been approved by all co-authors and responsible authorities at the institute or organization where the work has been carried out.

  5. Copyright has not been breached in seeking publication of the submission.